Clinical Trial Update: A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing two strengths of insulin lispro in patients with Type 1 diabetes mellitus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Admelog (insulin lispro)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED